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A B S T R A C T   
Snakebite envenoming is a neglected tropical disease that may claim over 100,000 human lives annually 
worldwide. Snakebite occurs as the result of an interaction between a human and a snake that elicits either a 
defensive response from the snake or, more rarely, a feeding response as the result of mistaken identity. 
Snakebite envenoming is therefore a biological and, more specifically, an ecological problem. Snake venom itself 
is often described as a “cocktail”, as it is a heterogenous mixture of molecules including the toxins (which are 
typically proteinaceous) responsible for the pathophysiological consequences of envenoming. The primary 
function of venom in snake ecology is pre-subjugation, with defensive deployment of the secretion typically 
considered a secondary function. The particular composition of any given venom cocktail is shaped by evolu-
tionary forces that include phylogenetic constraints associated with the snake’s lineage and adaptive responses to 
the snake’s ecological context, including the taxa it preys upon and by which it is predated upon. In the present 
article, we describe how conceptual frameworks from ecology and evolutionary biology can enter into a mutually 
enlightening relationship with clinical toxinology by enabling the consideration of snakebite envenoming from 
an “ecological stance”. We detail the insights that may emerge from such a perspective and highlight the ways in 
which the high-fidelity descriptive knowledge emerging from applications of -omics era technologies – “ven-
omics” and “antivenomics” – can combine with evolutionary explanations to deliver a detailed understanding of 
this multifactorial health crisis.   
1. Evolutionary ecology and clinical impact of snake venoms—a 
brief introduction 
Venomous snakes share a long co-evolutionary history with 
primates, including our ancestors: their continuous co-existence across 
Africa (since ~6.7 My) and more recently (last ~2.5 My) in Asia, has 
shaped selection pressures for both lineages (Harris et al., 2021; 
Kazandjian et al., 2021). In our world today, humans and venomous 
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snakes coexist in tropical and subtropical rural regions. While a certain 
level of human ophidian accidents is inevitable, habitat reshaping due to 
agricultural and other practices, and climate change, contribute to 
increasing the level of human-snake interactions and, thus, the inci-
dence of snakebites (Gutiérrez, 2020). Legitimate snakebite envenom-
ings inflicted on humans by any of the approximately 110 species 
included in the World Health Organisation’s (WHO) category 1 (highest 
medical importance) are an occupational hazard and a disease of 
poverty in many tropical regions (Harrison et al., 2009). The majority of 
envenoming from these snakes, which either belong to the Viperidae or 
Elapidae family (WHO, 2017), occur during capricious encounters with 
people engaged in rural activities in tropical and subtropical regions, 
especially in Asia and Africa. Such encounters can be described as 
ecological interactions between snakes and humans (Jackson et al., 
2019; see below). Literature reports estimate that 400,000–1,200,000 
snakebite envenomings occur annually, causing 81,000–138,000 deaths 
and many more injuries, such as physical sequelae (stigmatising disfig-
urements and amputations) and chronic mental morbidity (Gutiérrez 
et al., 2017a). 
Snakebite envenoming affects not only the victims but often their 
entire families, which may enter a cycle of generational poverty that is 
difficult to break. In spite of its magnitude, the problem of snakebite 
envenoming has historically faced a neglect: therapeutic antivenoms are 
scarce or even unavailable in many regions (Longbottom et al., 2018); 
knowledge regarding the venoms/toxins and their pathophysiological 
actions is relatively limited; and modern biotechnological tools such as 
humanised or fully human antibodies still seem far from being intro-
duced into active therapeutic deployment. Recent international efforts 
fostered by the WHO, science-funding agencies, and other stakeholders 
including Médecins Sans Frontières, the Wellcome Trust, the Kofi Annan 
Foundation, and the Global Snakebite Initiative (Chippaux, 2017; 
Longbottom et al., 2018; Harrison et al., 2009), are attempting to reverse 
this neglect and reduce the mortality and disability from snakebite 
envenoming worldwide by 50% before 2030 (WHO, 2019). 
Snakebite envenoming represents a One Health challenge requiring 
clinical, ecological, and public health expertise (Longbottom et al., 
2018). Hence, to comprehensively address this disease burden, the 
clinical challenge of appropriate case diagnosis needs to be considered 
within an ecological evolutionary context. Throughout this manuscript 
we reflect on the meaning, experimental methodologies, application and 
interpretation of shared or specific concepts of the partly overlapping 
domains of ecological and clinical toxinology. We argue that increased 
knowledge of snake behavior and life-history traits are crucial for un-
derstanding and predicting the frequency and geographical distribution 
Fig. 1. Snake species of the family Elapidae whose venoms have been studied by using proteomic tools (names indicated in red) among all snake species within this 
family (371; based on lists provided by www.reptile-database.org). As shown in the inset pie chart, studied species cover 24% of all elapids. ▸ and * denote, 
respectively, the availability of specific venom gland transcriptome and genome sequence. Species whose venom proteome was gathered using top-down MS are 
underlined. Last update: April 26, 2021. 
J.J. Calvete et al.                                                                                                                                                                                                                               
Toxicon: X 9–10 (2021) 100070
3
of snakebites (Jackson et al., 2019). Furthermore, knowledge of the 
evolutionary ecology of venomous snakes and the identity of the most 
relevant toxin molecules in the context of prey capture and human 
envenoming, are both key for improving our understanding of both the 
underlying pharmacology and the ability to improve the efficacy of 
antivenoms—the only effective antidote for envenoming. This remains a 
major challenge, as nearly half of all snake species capable of inflicting a 
life-threatening bite do not have antivenoms on the market, and distri-
bution pipelines in the most afflicted countries are often substandard 
(WHO, 2017). 
Venoms are intrinsically ecological traits (Jackson et al., 2019) and 
their natural history should thus be understood in the context of a 
network of chance and selection events. Identifying the specific pres-
sures that tailored the composition of extant medically relevant venoms, 
e.g. by inferring influential nodes across phylogeny (Calvete, 2013, 
2019; Pla et al., 2013, 2017a; Gibbs et al., 2013; Lomonte et al., 2014; 
Blanchet et al., 2017; Calvete et al., 2017; Ainsworth et al., 2018; Sanz 
et al., 2019a; Zaher et al., 2019; Jackson and Koludarov, 2020; 
Kazandjian et al., 2021; Holding et al., 2021), may have implications for 
the clinical treatment of human envenomings. The thesis advocated in 
this essay is that integration and contextualisation of complementary 
evolutionary, ecological, and clinical toxinological information repre-
sents a powerful holistic approach to tackle the global challenge of snake 
envenoming. 
2. Evolutionary and contemporary contexts of snake venoms 
Venoms are bioactive secretions typically consisting of cocktails of 
secretory proteins collectively referred to as toxins. Venoms have 
evolved independently in over a hundred animal lineages, where they 
are key evolutionary innovations that play a wide range of important 
ecological roles that predominantly involve predation and/or defense 
(Casewell et al., 2013; Schendel et al., 2019). One such lineage is cae-
nophidian snakes, which explosive radiation in the wake of the Creta-
ceous–Paleogene mass extinction approximately 60–50 million years 
ago (Hsiang et al., 2015), was perhaps a consequence of the evolution of 
Fig. 2. Snake species of the family Viperidae whose venoms have been studied by using proteomic tools (names indicated in red) among all snake species within this 
family (355; based on lists provided by www.reptile-database.org). As shown in the inset pie chart, studied species cover 35% of all viperids. ▸ and * denote, 
respectively, the availability of specific venom gland transcriptome and genome sequence. Species whose venom proteome was gathered using top-down MS are 
underlined. Last update: April 26, 2021. 
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venom (Fry et al., 2006, 2012). Snake venom is thought to have evolved 
primarily as a trophic adaptation, that is for predatory purposes (Davies 
and Arbuckle, 2019; Ward-Smith et al., 2020), and among the ca. 3700 
extant snakes, at least 800 species (within Elapidae, Viperidae, Colu-
bridae and Atractaspididae) use venom to immobilize their invertebrate 
or vertebrate prey before swallowing it whole. Venom is also used 
defensively by many snakes, and several lineages of venomous snakes 
have evolved specialised defensive venom adaptations (Arbuckle et al., 
2017; Calvete, 2017), such as the blindingly cytotoxic venoms of the 
three lineages of spitting cobra (Kazandjian et al., 2021) and the 
hyperalgesic venoms of micrurine snakes (Bohlen et al., 2011; Lomonte 
et al., 2016; Sanz et al., 2019b). 
To achieve their predatory and defensive functions, snake venom 
arsenals comprise mixtures of dozens to hundreds of bioactive com-
pounds that belong to a limited number (2 < n < 20) of protein families 
(Fry et al., 2009; Calvete, 2013; Junqueira-de-Azevedo et al., 2016; 
Tasoulis and Isbister, 2017; Barua and Mikheyev, 2019), suggesting that 
relatively few protein folds are amenable for evolving a toxic role (Reeks 
et al., 2015). As in other venomous lineages, each of these protein toxin 
families represent molecular phenotypic innovations or novelties that 
emerged through functional recruitment of single-copy gene products, 
gene duplication massive structural and functional diversification, or 
both (Zancolli and Casewell, 2020). Interestingly, venom proteomics 
evidence gathered from 236+ snake species, mainly within the families 
Elapidae (Fig. 1) and Viperidae (Fig. 2), has revealed that variation in 
venom composition -within- and between-species, in-space (geographic) 
and in-time (ontogenetic)- is a common feature at all taxonomic levels. 
Much of this variation is due to differences and changes in prey 
composition, highlighting the influence that trophic ecology has on the 
evolution of snake venom. Importantly, this influence of ecological 
factors also extend to other venom-associated traits and characters—the 
venom system— including both morphological and behavioural traits 
(Kazandjian et al., 2021; Westeen et al., 2020). Extant venomous snakes 
thus represent fascinating models for studying the emergence of novel 
functional traits within clear adaptive contexts and across multiple 
levels of biological complexity that span from molecule to morphology 
to behavior (Casewell et al., 2013; Schendel et al., 2019; Zancolli and 
Casewell, 2020; Post et al., 2020; Jackson and Koludarov, 2020). 
The genome contains traces of sterile recombination events as well as 
those that have contributed to the functional genome of the extant 
species. However, snake genomics is in its infancy. The first genome 
draft of a venomous snake, the king cobra (Ophiophagus hannah), was 
published in 2013 (Vonk et al., 2013). Since then, the sequences of only 
a handful of venomous snake genomes have been compiled, including 
the speckled rattlesnake (Crotalus mitchellii) (Gilbert et al., 2014); the 
five-pacer viper (Deinagkistrodon acutus) (Yin et al., 2016); the habu 
snake (Protobothrops flavoviridis) (Shibata et al., 2018); the prairie rat-
tlesnake (Crotalus viridis) (Schield et al., 2019); two hydrophiins 
(Hydrophis melanocephalus and Emydocephalus ijimae) and two lat-
icaudins (Laticauda laticaudata and L. colubrina) (Kishida et al., 2019); 
the Shaw’s sea snake (Hydrophis curtus) (Peng et al., 2020); the western 
diamondback rattlesnake (Crotalus atrox) (Giorgianni et al., 2020); the 
Indian cobra (Naja naja) (Suryamohan et al., 2020); the tiger rattlesnake 
(Crotalus tigris) (Margres et al., 2021); the olive sea snake (Aiysurus 
laevis) (Ludington and Sanders, 2021), and the jararaca (Bothrops jar-
araca) (Almeida et al., 2021). The foreseeable exponential growth of 
comparative snake genomics studies in the coming years (Kerkkamp 
et al., 2016; Drukewitz and von Reumont, 2019) will undoubtedly result 
in a major leap forward in our understanding of the deep history of 
venom evolution. In addition, the comprehensive catalog of 
venom-gland-specific toxin genes complemented with transcriptomics, 
venomics and toxinological information may pave the way for the 
generation a la carte of synthetic antivenoms. 
3. Snakebite and the “ecological stance” 
Snakebite envenoming is a biological problem and understanding a 
biological problem requires a biological lens. Biology is a science of 
complex functional systems with myriad sub-components of endless 
variety. Nonetheless, certain basic principles appear to hold across all 
biological systems. Acknowledgement of these basic principles should 
therefore be a core component of any attempt to understand biological 
systems and thereby solve (or mitigate) biological problems. Two of 
biology’s fundamental principles are evolution – all biological systems 
evolve and have an evolutionary history – and ecology – all biological 
systems interact with other biological systems. These principles hold at 
all levels of analysis within biology, from the molecular to the organ-
ismal. Evolution and ecology themselves share a common principle – the 
transcendent role of context. In biology, what things are determined by 
their context – both their temporal and “genetic” context in an evolu-
tionary lineage, and their extant context in an ecological assemblage. 
Again, this applies to molecules as much as it applies to organisms 
(Guttinger, 2018; Jackson and Koludarov, 2020). An appreciation of the 
role of context thus seems to be a core component of a minimal bio-
logical perspective – an evolutionary or ecological stance, akin to the 
“intentional stance” (Dennett, 1995) or “empirical stance” (van Fraas-
sen, 2008). These “stances” represent heuristic strategies for under-
standing and getting to grips with phenomena. Here, we will discuss 
three ways in which the evolutionary and ecological stances, with their 
shared emphasis on context, may help us get to grips with the problem of 
snakebite envenoming. 
3.1. Circumstances of bites 
Snakebite itself, the result of an interaction between a snake and a 
human, is an uncontroversial ecological phenomenon. One of the most 
important factors in reducing the burden of snakebite envenoming is 
gaining detailed knowledge of the circumstances in which bites occur. 
Such knowledge may help prevent many snakebites from occurring, thus 
reducing the burden on healthcare services. What are the contexts in 
which snakebites occur? Answering this question requires knowledge of 
the ways in which snake ecology and human ecology become human- 
snake ecology. Currently we have much anecdotal evidence on the cir-
cumstances of bites, but very little research has been conducted in this 
space. 
Naturally, the context of bites differs considerably from place to 
place, both regionally and locally. Thus, the circumstances in which 
bites occur in India may or may not exist in (for example) sub-Saharan 
Africa. Thus, ecological studies of human-snake interactions must be 
conducted in all snakebite-afflicted regions. Some examples of simple, 
testable hypotheses include:  
• Do snakebites typically occur when a snake is attempting to defend 
itself from a human it perceives as a potential threat?  
• Are bites to sleeping humans (e.g. by spitting cobras in Africa and 
kraits in India) a case of mistaken identity – when a confused snake 
mistakes the smell of a human for that of the mammalian (e.g. ro-
dent) prey it seeks – or can be considered defensive (e.g. when a 
sleeping human accidently rolls over onto a snake that was seeking 
warmth)?  
• Does carrying a torch at night or wearing appropriate footwear 
reduce the incidence of snakebite?  
• Does clearing away rubbish or overgrown vegetation from around 
human dwellings reduce the number of human-snake interactions? 
Questions like these can be combined to elaborate an educational 
program to instruct people about the behavior of snakes in their area, 
which may lead to a significant reduction in snakebites. 
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3.2. Molecular evolution and function of toxins 
The composition and activity of snake venoms is strongly influenced 
by the feeding ecology of the snakes that deploy them, often resulting in 
compositional variation across biogeographical regions and develop-
mental stages (Sunagar et al., 2016; Jackson et al., 2019). However, the 
mechanisms that generate this variation remain largely elusive, partly 
due to the paucity of both venomous and non-venomous snake genomic 
data (e.g., Aird et al., 2017). The evolution of this continuous spectrum 
of venom phenotypes is best understood through the application of 
quantitative genetic methods (Hansen and Houle, 2008; Walsh and 
Lynch, 2018), which have yet to be applied to snake venom systems. In 
addition, identifying the ecological correlates of particular venom 
mixtures from the current composition of venoms is not straightforward: 
We must take into account both phylogenetic constraints and the 
potentially confounding effect of having to use atypical prey species as 
models to measure venom potency and bioactivities (see below). 
Contrasting our lack of knowledge on the mechanisms that underlie 
the population and developmental variational properties and dynamics 
of snake venoms, we have a much better knowledge about the processes 
that shape snake venoms on macroevolutionary scales (between spe-
cies). For example, we can infer nodes where particularly influential 
shifts were made in genotype-phenotype space by mapping the venom 
phenotype profiles of a species clade across its phylogeny (Pla et al., 
2013, 2017a; Gibbs et al., 2013; Lomonte et al., 2014; Calvete et al., 
2017; Ainsworth et al., 2018; Calvete, 2019; Sanz et al., 2019a; Zaher 
et al., 2019; Kazandjian et al., 2021). Further, ancestral structure 
inference may allow the reconstruction of the evolutionary origin of key 
mutations across the history of individual toxins (Whittington et al., 
2018) and functional snake venom clades (Blanchet et al., 2017; Ains-
worth et al., 2018; Jackson and Koludarov, 2020; Holding et al., 2021). 
3.3. The effectiveness or “ecological validity” of therapeutics 
“Ecological validity” is a concept with a long history in psychology 
and refers to the generalizability of data from one context (e.g. the 
laboratory) to another (e.g. the world outside the laboratory) 
(Schmuckler, 2001). Whilst the term might not be commonly used in 
association with the design and development of snakebite therapeutics, 
it is a familiar concept within pharmacological studies – a drug may be 
effective in vitro without those promising results being translated to in 
vivo contexts. This may be described as the difference between “efficacy” 
and “effectiveness”, a distinction that has been previously highlighted in 
research on snake antivenoms (Isbister, 2010). Whether or not a 
snakebite therapeutic (e.g. an antivenom) is ecologically valid is partly 
determined by factors including whether or not an antibody that binds a 
toxin under laboratory circumstances will do so under physiological 
circumstances; whether binding a toxin translates to neutralisation (or 
elimination); whether the biodistribution of injected antibodies (or 
other therapeutics) is comparable to that of their targets (e.g. toxins); 
and a host of other factors. In addition to these molecular and physio-
logical factors, the ecological validity of a snakebite therapeutic is 
influenced by the simple fact of whether the therapeutic can be deliv-
ered to a bite victim in a timely manner. Thus, as the World Health 
Organisation’s Snakebite Envenoming Roadmap indicates (WHO, 
2019), antivenom/drug distribution programs and other aspects of 
health infrastructure are crucial components in determining the 
ecological validity of a potential snakebite therapeutic. Much like any 
other functional trait—tools such as drugs can be considered part of an 
extended phenotype (Dawkins, 1982) of the human organism—the 
effectiveness of a snakebite therapeutic is contingent on its deployment 
in the appropriate context. Studying and engineering (e.g., through the 
creation of efficient distribution pipelines; the training of clinicians; 
etc.) this context is part of the landscape of snakebite research. 
3.4. The evolutionary ecology of venoms and its impact on snakebite 
Being primarily a trophic adaptation, the composition and potency of 
a snake venom is shaped by complex intrinsic (the genetic propensities 
of a lineage) and extrinsic (ecological interactions and environmental 
conditions) factors (Casewell et al., 2014, 2020; Sunagar et al., 2016). 
Hence, understanding the evolutionary ecology of venom becomes 
invaluable, not only from an academic perspective but also for designing 
efficient snakebite therapeutics. Ecological factors that are well-known 
to affect snake venoms include feeding ecology, ontogeny, predator 
pressure, inter- and intraspecific competition, and geographic distribu-
tion and population ecology. 
Variations in snake venoms are believed to be primarily driven by 
differences in the physiologies of the prey and/or predatory animals 
against which venom is deployed and are especially pronounced in 
snake species that are distributed across distinct biogeographical or 
agroclimatic zone. Dietary shifts, which may result from transitions in 
Fig. 3. Median Lethal Dose (LD50) estimates (95% CI, i.p. route) for several Neotropical pitvipers in three models of preys (mouse, Mus musculus; lizard, Hemidactylus 
frenatus; anuran, Engystomops pustulosus). Species that consume regularly lizards and frogs are highlighted from those that specialize in mammals by asterisks. 
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ecological niches, or from the differences in prey abundance from one 
region to another, have led to the extensive evolutionary fine-tuning of 
the snake venom cocktail (Daltry et al., 1996; Gibbs et al., 2011). The 
effect that dietary modifications and food specialisations have on the 
venom’s composition has some restrictions since there appears to be a 
gradient of susceptibility to venom among different prey types. Thus, 
anurans appear to be much more resistant to snake toxins than lizards 
and rodents, sometimes by several orders of magnitude, even in species 
that feed on them regularly (Fig. 3). 
Asiatic kraits (Bungarus spp.) provide an instructive example of the 
effects of such dietary shifts and feeding specialisations on snake 
venoms. Kraits that chiefly feed on mammals secrete some of the most 
potent and medically important venoms to humans (Sunagar et al., 
2021) whereas those that specialize in feeding on reptiles possess 
venoms with greatly reduced toxicity to mammals (Senji Laxme et al., 
2019). Similar shifts in diet from mammals to arthropods (Barlow et al., 
2009; Senji Laxme et al., 2019), amphibians (Hutchinson et al., 2007), 
birds (Mackessy et al., 2006), and eggs of various animals (Li et al., 
2005) have significantly influenced the compositions and toxicities of 
snake venoms and, in some cases, their delivery systems. 
As venoms play an essential role in prey incapacitation and, perhaps, 
predigestion, dietary shifts that are associated with developmental stage 
or ontogeny can alter venom compositions across the lifetime of an in-
dividual snake (Mackessy et al., 2003; Gibbs et al., 2011; Jackson et al., 
2016). A shift in prey preference, from ectotherms as juveniles to en-
dotherms as adults, is associated with changes in the venom profiles of 
various species of Crotalus snakes (Mackessy et al., 2003). Paedomor-
phosis (i.e., the retention of larval or juvenile traits into adulthood) has 
been noted in some species (e.g., Crotalus durissus (Calvete et al., 2010); 
Pseudonaja modesta (Jackson et al., 2016)). Dichotomous venom profiles 
are documented in others, in which the juvenile snakes possess a 
neurotoxin-rich venom as opposed to the proteolytic venoms of their 
adult counterparts (e.g. Crotalus simus (Durban et al., 2013), P. textilis 
(Jackson et al., 2016; Cipriani et al., 2017)). While the underlying mo-
lecular mechanisms remain in most cases uninvestigated, it has been 
suggested that microRNAs (miRNA) play a role in underpinning such 
stark transitions in the proteomic compositions of venoms across the 
ontogeny of the Central American rattlesnake (Crotalus simus simus) 
(Durban et al., 2013). Snake venoms and their molecular targets in prey 
and/or predators can exert reciprocal selection pressures. The clearest 
example of selection pressure towards venom resistance is in predators 
(e.g., opossums (Marsupialia: Didelphidae) and mongoose, Herpestes 
ichneumon) preying on venomous animals (Voss and Jansa, 2012; Dra-
beck et al., 2015; Holding et al., 2016). On the other hand, the evolution 
of adaptive resistance in ground squirrels (Spermophilus beecheyi) against 
the venom of the Northern Pacific rattlesnake (Crotalus viridis oreganus) 
represents another example of evolutionary chemical arms races be-
tween a venomous snake and its prey (Holding et al., 2016; Margres 
et al., 2017; Gibbs et al., 2020). While several molecular mechanisms of 
resistance are clearly understood, the precise impact of venom resis-
tance on venom composition and potency remains elusive. 
In addition to biotic interactions, environmental conditions are a 
primary influence on the abundance of predators and prey in a region 
and, in turn, influence snake venom cocktails. In addition, many 
extrinsic factors, including humidity, temperature and altitude can 
determine the rate of transcription and translation (i.e., RNA and protein 
synthesis, respectively). Hence, the environment may directly or indi-
rectly influence venom profiles in a multitude of ways. It is unsurprising, 
therefore, that considerable variation in venom compositions and tox-
icities have been documented in snakes with large geographical distri-
butions across distinct biogeographic conditions (Strickland et al., 2018; 
Senji Laxme et al., 2021). Considerable differences in snake venoms 
have also been described at finer geographical scales (Glenn et al., 
1983). While the underlying causes are mostly unknown, this variability 
may stem from subtle differences in microhabitat, dietary preference, 
intraspecific competition, and venom resistance in local prey at all 
taxonomic levels. 
As with evolutionary diversification more broadly, venom variation 
arises from the interaction between a plethora of intrinsic factors with 
those that are extrinsic (described in the preceding paragraphs). This 
interaction is an example of the transcendent role of context in evolu-
tion, in which an organism’s environmental context (i.e., extrinsic fac-
tors) influence trait evolution in a manner that is both constrained and 
facilitated by the organism’s phylogenetic context (i.e., factors intrinsic 
to an organismal lineage). Many genetic mechanisms including gene 
duplication, domain loss, neofunctionalisation, pseudogenisation, 
evolutionary tinkering of expression levels, alternative splicing, trans- 
splicing, and gene co-option have been identified as influencing the 
molecular diversification of snake venoms (Sunagar et al., 2016; Case-
well et al., 2020). While positive Darwinian selection is implicated in 
rapidly introducing sequence variations in venom coding genes (Lynch, 
2007; Juárez et al., 2008; Sunagar et al., 2013), mostly in an episodic or 
a ‘two-speed’ fashion (Sunagar and Moran, 2015), venom variation can 
also arise from the phylogenetic divergence of snakes over time. Cryptic 
genetic divergence in clinically important species can be detrimental to 
snakebite therapy, as antivenoms raised against the venom of one 
lineage may not be efficient in neutralising toxin variants in genetically 
distinct snakes. The existence of cryptic evolutionary lineages within a 
single species, therefore, can have tremendous implications for snake-
bite treatment, as can the existence of phenotypic crypsis in distinct 
species with overlapping range-distributions (Carbajal-Márquez et al., 
2020; Sunagar et al., 2021). More infrequently, evolutionary conver-
gence may result in cryptic lineages which are relatively inconsequential 
to snakebite therapy, given the convergence of venom composition 
along with the rest of the phenotype (Ukuwela et al., 2012). 
4. What’s in a venom? 
For more than a century, biochemists and pharmacologists have 
found snake venoms to be a rich and exciting ground for the discovery of 
novel molecules, mainly polypeptides, with a broad array of potent and 
specific bioactivities that explain their toxicity. Research on venoms has 
been continuously enhanced by technological advances, and a paradigm 
shift in the study of snake venoms came with the introduction of ’-omic’ 
technologies at the turn of third millennium of our calendar (Fig. 4). 
However, proteomic strategies used to analyze venoms (“venomics") in 
different laboratories have been diverse and no general consensus has 
been adopted among molecular toxinologists that would facilitate 
comparison of results. For the most part, venomics studies have used 
peptide-centric ‘bottom-up’ approaches, with pre-mass spectrometry 
Fig. 4. Cumulative number of published studies dealing with the proteomic 
characterisation of snake venoms. Starting with pioneer works in 2003, up to 
mid-2020, a sustained increment in publications is evidenced (light blue bars). 
The inset pie chart illustrates the proportion of venomic studies that correspond 
to snake species from Elapidae (43%) (Fig. 1) and Viperidae (57%) (Fig. 2). 
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(MS) venom decomplexation, or applying direct ‘shotgun’ approaches 
(Fox and Serrano, 2008; Calvete, 2014; Zelanis and Tashima, 2014; 
Eichberg et al., 2015; Lomonte and Calvete, 2017). 
An important challenge in the characterisation of venoms (and other 
complex biological samples) is the inability of any single method to 
provide a complete view of its proteome. Proteome decomplexation and 
toxin identification and quantification represent major pillars of current 
state-of-the-art snake venom proteomics. Sample decomplexation pro-
tocols can be categorised as gel-based and gel-free methods (reviewed by 
Lomonte and Calvete, 2017). Among the multiple hyphenated ap-
proaches proposed by different research groups for integrating pre-MS 
venom proteome decomplexation and the identification and quantifi-
cation of the individual toxins into a single workflow, arguably the most 
successful combination has turned out to be the one that takes advantage 
of venom fractionation to simultaneously quantitate the relative abun-
dances of its different venom components. This strategy, which is usu-
ally referred to as ‘snake venomics’ (Juárez et al., 2004), relies on 
reverse-phase chromatographic decomplexation and eluate monitor-
isation at the absorbance wavelength of the peptide bond to estimate the 
relative abundances of the chromatographically separated fractions by 
peak area integration (Calvete, 2014, 2018). Among the gel-based 
approaches, two-dimensional electrophoresis (2-DE) generates an 
overview of a venom’s protein complexity in a single image, including 
the approximate number of protein species and their apparent molecular 
masses and isoelectric points. In addition, comparison of non-reduced 
(IEF)/non-reduced (SDS-PAGE) and non-reduced/reduced 2-DE gels 
provides information on the quaternary structure of the venom proteins 
(Rabilloud, 2002; Eichberg et al., 2015). However, small (<3 kDa) 
peptides, which represent abundant components of some snake venoms, 
as well as proteins exhibiting extreme isoelectric points, may not be 
visualised in 2-DE venom reference maps, and there are a number of 
challenges in 2-DE proteome quantification: some spots tend to have 
severe tails in either dimension; contrast variations due to stain expo-
sure, geometric distortions due to casting, polymerisation, and the 
running procedure may confound spot modeling, challenging reliable 
spot volume quantification. 
Gel-free LC-MS shotgun approaches often bypass the initial sample 
decomplexing step, and instead, the entire protein mixture is enzymat-
ically digested into peptides that are subjected to mass spectrometric 
analysis (Wolters et al., 2001; Wu and MacCoss, 2002; Zhang et al., 
2013). Conceptually, label-free quantification approaches are relatively 
straightforward, and are typically used to compare abundance changes 
Fig. 5. Panel A, generalised representation of label-free shotgun proteomics. Both control and treatment samples are separately prepared and subjected to individual 
mass spectrometric analysis. In shotgun, or bottom-up proteomics, proteins are enzymatically digested into peptides, often with trypsin, prior to mass spectrometry. 
Label-free quantification (LFQ) is based on comparison of the areas of the peptide precursor ions of the same peptide, or by counting the number of fragment ion 
spectra of the same protein, in the different analyses. Appropriate comparisons are highlighted by the green ✓. Red X highlight that label-free strategies are not 
appropriate for determining the abundances of different proteins in a single sample: in this example, there is no change in abundance for protein B between control 
and treatment samples, whereas protein A is most abundant in the treated sample. Panel B, simulation of the different outcomes of label-free quantification of the 
same shotgun-generated tryptic venom peptidome when a species-specific genomic/transcriptomic reference database is available (a) or not (b) to match the tryptic 
peptide set. 
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of the same protein in different analyses. For example, comparing the 
abundance changes of protein A in control vs protein A in treated 
samples (Fig. 5A; Zhu et al., 2010; Neilson et al., 2011). In contrast, mass 
spectrometry is essentially a non-quantitative technique because pro-
teolytic peptides exhibit a wide range of physicochemical properties that 
influence their ionisation efficiency, and hence, the quantitative esti-
mations of parent protein abundances by label-free shotgun approaches 
is not appropriate for determining the abundances of different proteins 
in a single sample (Neilson et al., 2011; Lee et al., 2019). This point is 
discussed in more detail below. On the other hand, shotgun venomics, 
particularly when LC-MS data can be matched against a next generation 
species-specific venom gland transcriptome, may provide a deep cata-
logue of the protein/peptide components present in a venom (Rokyta 
et al., 2011; Aird et al., 2013; Calvete et al., 2018a). However, among 
the 236+ nominal snake species within families Elapidae and Viperidae 
that have their venom proteomes characterised through MS-based ven-
omics, only for 114 taxa has the venom gland transcriptome been re-
ported, and venom gland transcriptomes are also available for another 6 
species whose venom proteomes have not been analysed (Figs. 1 and 2). 
In the absence of a reference transcriptomic database, the data gathered 
through shotgun the relationship of shotgun MS/MS-derived peptides to 
their intact parent molecules may be lost, or very difficult to reconstruct 
(e.g., in the case of highly similar isoforms). With the advancement of 
next-generation approaches to sequence and assemble shotgun omics 
data, the limitation to generate a transcriptomic database is not tech-
nical but has more to do with accessibility to the necessary biological 
material, e.g. venom gland tissue. Very stringent national wildlife pro-
tection laws, notably the Wildlife Protection Act, 1972 in India, a 
country home to more than 60 species of venomous snakes some of 
which are sufficiently common to cause severe human envenomings 
(Whitaker and Captain, 2004), severely hinders the collection of venom 
and snake tissues for scientific research. 
Recent venomics studies have applied standalone ‘top-down’ (TD) 
MS or combined top-down and bottom-up approaches (Petras et al., 
2015, 2016, 2019; Göçmen et al., 2015; Melani et al., 2016; Ainsworth 
et al., 2018; Pla et al., 2018; Hempel et al., 2020; Kazandjian et al., 
2021). Compared to bottom-up peptide-centric methods, top-down 
venomics has the capability to resolve the venom proteome to the 
level of individual proteoforms or closely related isoforms. On the other 
hand, TD-MS requires higher resolution instrumental configurations 
with extended mass-to-charge range to isolate and fragment multiply 
charged monoisotopic ions and interpret the resulting complex frag-
mentation patterns of daughter ions. A major limitation of current snake 
venomics arise from the paucity of genomic and venom gland tran-
scriptomic sequence information for venomous snakes in public domain 
databases (Brahma et al., 2015; Drukewitz and von Reumont, 2019). 
This limitation is more pressing in the case of TD venomics, where the 
upper mass limit for efficient fragmentation and the poor understanding 
of the mechanism of gas-phase dissociation, makes the automatic 
interpretation of the complex fragmentation spectra of native protein 
ions impractical without specific database support. Conversely, in 
bottom-up venomics of orphan organisms, algorithms for aiding in the 
automated de novo interpretation of fragmentation mass spectra are 
becoming powerful tools. In addition, though demanding a high level of 
user skill, manual de novo sequencing of high-quality fragmentation 
spectra followed by BLAST analysis of the deduced sequence remains 
another valid option for low-throughput identification of venom pro-
teins from poorly studied venoms. 
5. The evils of quantification 
The abundance and specific toxicity of the individual toxins are 
important features for inferring composition-activity correlations of 
venoms at any level of organisation, whether isolated from single 
snakes, within and between populations, or across phylogenetic clades. 
Mass spectrometry-based proteomics has emerged as a powerful tool for 
the global characterisation and quantification of proteins from complex 
biological samples (Cravatt et al., 2007; Han et al., 2008). However, 
intrinsic differences in the ionisation efficiency and/or detectability of 
peptide ions limit the applicability of label-free inferences to directly 
estimate relative parent protein abundances. Precise quantification of 
proteins generally requires modification of standardised protocols, and 
is contingent upon the specific scientific question being addressed, the 
proteome being investigated, and the type of sample being analysed 
(Megger et al., 2013). Further, the experimental workflow is largely 
dependent on the availability of comprehensive protein sequence da-
tabases. Hence, while ongoing and completed genome sequencing pro-
jects have resulted in high-quality reference databases for many model 
organisms (Collins et al., 2003), the lack of comprehensive protein 
sequence databases represents a major challenge for proteomic in-
vestigations of non-model organisms (Carpentier et al., 2008; Armen-
gaud et al., 2014; Heck and Neely, 2020), such as the majority of 
venomous snakes. However, this situation may rapidly improve. Thus, 
not counting subspecies or distinct conspecific populations, there are 
114+ venom gland transcriptomes available in the NCBI TSA (Tran-
scriptome Shotgun Assembly Sequence) and/or the SRA (Short Read 
Archive) (Figs. 1 and 2), and if species clade transcriptomics becomes 
the trend (Kazandjian et al., 2021; Holding et al., 2021) the snake venom 
gland transcriptomics database will see significant growth in the im-
mediate future. 
The strategy of label-free quantification by spectral counting or ion 
intensity is based on the assumption that the likelihood of data- 
dependent precursor ion selection is higher for abundant precursor 
ions, and that the number of peptide identifications, normalised to ac-
count for the fact that larger proteins tend to contribute more peptide/ 
spectra (Powell et al., 2004), represents a proxy of the abundance of the 
parent protein. A normalised spectral abundance factor (NSAF) is 
calculated as the number of spectral counts identifying a protein “i" 
(SpCi), divided by the protein’s length (Li), divided by the sum of SpC/L 
for all proteins in the experiment. Despite label-free proteome quanti-
fication strategies being developed for model organisms for which 
comprehensive genomic or transcriptomic databases are available, and 
thus protein identifications (SpCi) does not represent a limiting factor 
(Old et al., 2005), there has been increased use of label-free shotgun 
proteomic techniques to characterize venom compositional patterns and 
estimate the relative abundance of individual proteins within the pro-
teome of non-model snake venoms, particularly by very active research 
groups in India (Kalita et al., 2018; Patra et al., 2019; Patra and 
Mukherjee, 2020) and Malaysia (Zainal Abidin et al., 2016; Tan et al., 
2016, 2018, 2019). The conceptual shortcoming of this approach results 
from the fact when a comprehensive reference database is missing, 
quantification is biased toward the successful peptide identifications 
(Liu et al., 2004; Tang et al., 2006; Bantscheff et al., 2007, 2012; Choi 
et al., 2008; Neilson et al., 2011) (Fig. 5B). Instead, deriving reliable 
quantitative information from peptide-centric MS data should be based 
on an unbiased procedure, e.g., where there is complete coverage of the 
venom toxin transcriptome. 
The “snake venomics" proteome quantification strategy, which uses 
offline pre-MS two-separation step (reverse-phase HPLC and SDS-PAGE) 
to decomplex and quantify the venom proteome (Calvete, 2014; Eich-
berg et al., 2015; Calvete, 2017), fulfills this condition. It is worth 
mentioning that unlike “label-free" strategies that refer to unitless fig-
ures, the “snake venomics" proteome quantification strategy provides an 
estimate of the relative abundance of the venom’s toxin arsenal in per-
centage (mg/100 mg) of total venom proteins (Calderón-Celis et al., 
2016, 2017, 2019). Novel instrumental configurations have been pro-
posed that combine elemental and molecular mass spectrometry plat-
forms to achieve locus-resolved absolute quantification of the venom 
proteome (Calvete et al., 2017). Implementing top-down and absolute 
quantification approaches into next-generation mass spectrometry sys-
tems promises a quantitative leap, in proteomics in general, and for the 
study of venoms in particular. Although not discussed in this work, a 
J.J. Calvete et al.                                                                                                                                                                                                                               
Toxicon: X 9–10 (2021) 100070
9
thorough characterisation of venom peptidomes, protein glycosylations, 
and other post-translational modifications, will be a relevant and 
necessary task to complete our understanding of ’what’s in a venom’. 
6. The road to integrative snake venomics 
As addressed above, an increasing trend in venom analysis is “clade 
venomics", the identification of evolutionary trends across whole 
genera, taxonomic clades, and phylogenetic families. Clade venomics is 
contingent upon the specific scientific question to be addressed. This in 
turn implies that concepts, such as median lethal dose (LD50), must be 
interpreted differently depending on whether the question belongs to 
the ecology or clinical toxinology domain. Likewise, both ecological 
venomics and clinical venomics rely on complementary omic platforms 
that add new approaches to the study of venoms, contributing to the 
multidisciplinarity of the field. Venomics (sensu lato), “antivenomics" 
(Pla et al., 2017b; Calvete et al., 2018) and “toxicovenomics" (Lomonte, 
2015; Lauridsen et al., 2017) are three complementary pillars of the 
molecular toxinologist’s toolbox (Fig. 6). Strategic alliances between 
clade venomics, antivenomics and toxicovenomics highlight the versa-
tility and adaptability of the original ‘venomics’ concept to the 
distinctive research of the different venomics domains. 
6.1. Antivenomics provides key information to guide antivenom 
optimisation 
Antivenoms are critical life-saving biologicals consisting of immu-
noglobulins (or derived F (ab’)2 and Fab fragments) elicited by hyper-
immunisation of horses or sheep with venom(s) from the most medically 
relevant snakes in the region where the antivenom is intended to be 
deployed. A strategy coined ’antivenomics’ has been developed to 
evaluate the preclinical immunorecognition profile of an antivenom 
towards homologous and heterologous venoms. Successive “genera-
tions" of the antivenomics protocol have refined and extended its 
analytical scope (reviewed by Calvete et al., 2018). First generation 
consisted of the in-solution immunoprecipitation of antigen-antibody 
complexes followed by the chromatographic quantification of the 
uncomplexed venom proteins present in the supernatant (Lomonte et al., 
2008). Affinity chromatography-based second generation (2G) anti-
venomics (Pla et al., 2012) yielded smoother and better resolved chro-
matographic profiles of both the non-binding and the bound venom 
proteins. The antivenom’s toxin-resolved immunocapture ability can be 
estimated as the relative ratio of the chromatographic areas of the same 
protein recovered in the non-retained (NRi) and retained (Ri) affinity 
chromatography fractions using the equation: %NRi = 100 - [(Ri/(Ri +
Fig. 6. Cartoon of the exclusive and overlapping domains of Ecological Venomics and Clinical Toxinology, emphasising the mutually enlightening relationship 
between evolutionary and translational venomics, guided by an integrative knowledge platform on snake venoms, supported by their compositional (venomics, aided 
by databases provided by transcriptomics and genomics), functional (toxicovenomics), and immunological (antivenomics) characteristics. Studies on adaptive 
variations that have evolved via natural selection and enhance the snake foraging success on preferred prey belongs exclusively to the field of ecological venomics, 
whereas the identification of the relevant toxins that should be neutralised to reverse the symptoms of snakebites inflicted to non-prey animals, such as pets, farm 
animals, or humans, falls into the exclusive scope of clinical toxinology. It is hoped that the expansion of integrative venomics may facilitate a deeper understanding 
of biological (ecological venomics) and medical (translational venomics) aspects of snake venoms, as well as contribute to confront the problem of snakebite 
envenomings by guiding improvements in the design and production of improved antivenoms. 
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NRi)) x 100]. The inclusion of (R) in the equation compensates for 
possible losses during sample handling and chromatographic analysis, 
resulting in a more accurate quantification of the antivenom’s immu-
norecognition profile than with the immunoprecipitation method. 
Polyclonal antivenoms exhibit distinct affinity concentration-dependent 
patterns of maximal binding toward different toxins of the venom. 
Optimising the immunoaffinity conditions for all venom components 
seems an impossible mission. However, the maximal immunocapturing 
capacity of an antivenom can be determined by the parallel running of 
identical antivenom affinity columns incubated with increasing amounts 
of venom until saturation is reached. This modified antivenomics pro-
tocol has been dubbed third generation (3G) antivenomics (Pla et al., 
2017b). 
Antivenomics informs on the maximal binding capacity of an anti-
venom’s antibodies towards each of the venom toxins. However, the 
ability to bind toxins is an essential but not necessarily sufficient mo-
lecular property to endow an antivenom with clinical utility. A more 
relevant preclinical feature, the percentage of lethality neutralising an-
tivenom antibodies (%AVneutr) can be calculated from the combined 
outcome of antivenomics and in vivo neutralisation assay as the ratio 
[P]/Maxbind (Calvete et al., 2018; Sanz et al., 2018; Al-Shekhadat et al., 
2019; Sanz et al., 2020). [P] is the antivenom’s potency (P [mg venom 
neutralised per mass unit (mL or mg) that rescue 100% of the test 
population] = [(n-1)/ED50] x LD50), where “n" is the number of median 
lethal doses (LD50s) used as challenge dose to determine the median 
effective dose (ED50) of the antivenom in the murine model) (Araujo 
et al., 2008; Morais et al., 2010). Maxbind stands for the antivenom’s 
maximum toxin binding capacity. 
6.2. Toxicovenomics in ecological venomics: LD50, and the relevance of 
contextualising toxinological studies 
Antivenomics reveals information on the relative immunogenicity of 
the different venom components and quantifies the relative amounts of 
anti-toxin antibodies of an antivenom. However, venom toxins exhibit 
variable toxicity and it is the combination of abundance and potency 
that defines the ecological or clinical relevance of a toxin in the context 
of the venom injected into the prey or victim. Toxicovenomics aims to 
rank the different toxins present in a venom according to their contri-
bution to the venom LD50. To this end a Toxicity Score (TS) is calculated 
by dividing the toxin (TXi) abundance (in moles/g of total venom pro-
teins) by its median lethal dose (LD50) (in moles TXi/g animal body 
weight). The TS contributes to the identification of the most relevant 
toxins in a given venom (Calvete et al., 2010; Laustsen et al., 2015). The 
occurrence of taxon-preferent or taxon-specific toxins in certain venoms, 
particularly within the Colubridae family (Modahl et al., 2018; Modahl 
and Mackessy, 2019; Calvete et al., 2020), but also described in Micrurus 
(Elapidae) (Da Silva and Aird, 2001), underscores the importance of 
considering the adequate animal model for the purpose of the research 
aim (Jackson et al., 2019). Clearly, assessment of toxicity (median lethal 
dose, LD50) in the wild or in a controlled laboratory setting that mimics 
the natural ecosystem requires including natural prey in the study. 
Despite having stood the test of time, the LD50 is a somewhat coarse 
metric, which does not identify some important envenoming subtleties. 
The outcomes are reported at 24 or 48 h, which completely obscures 
events that occur during the first minutes of the envenoming. Under 
natural conditions, this period is crucial to the outcome of predation. 
The immobilisation or partial reduction of a prey’s escape abilities or 
total paralysis are central aspects of a venom’s efficiency (Fig. 7). For 
this reason, the knock-down time, the time to paralysis, could be a 
measure with greater biological significance when evaluating toxicity. 
The ecological limitations of the LD50 can be illustrated in the 
following example. The Duvernoy’s gland secretory proteome of the 
Costa Rican false coral snake Rhinobothryum bovallii comprises a handful 
of toxins belonging to only three protein families (Calvete et al., 2020). 
Major monomeric (86.5 mol%) and minor dimeric (2.8 mol%) 
three-finger toxins (3FTxs) dominate its venom arsenal. The remaining 
10.6% of the venom proteome comprises CRISP (8.2%) and PIII-SVMP 
(2.4%) molecules. Despite the large abundance of 3FTxs, a protein 
family whose elapid members are largely neurotoxic to mammals, in vivo 
lethality assays showed that R. bovallii venom is non-toxic to mice. Even 
intracerebroventricular injection of 100 μg of whole venom (containing 
Fig. 7. Changes in running speed after pitviper venom 
injection in the lizard Hemidactylus frenatus. Mean 
speed for four individuals before (black circle) and 
after (red circle) injection, tested on a 60 cm race 
track. Venoms from Atropoides picadoi, Crotalus simus, 
Porthidium nasutum, and Bothrops asper (juvenile) were 
tested. The first two species specialize in mammals; 
the last two include lizards in their diets. For any of 
the doses, lethal or sublethal, a significant decrease in 
escape velocity is observed few minutes after injec-
tion. In an ecological scenario, this reduction alone 
could represent an adaptive advantage for the snake.   
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67.2 μg of 3FTxs) was harmless to mice. Intraperitonal administration of 
50–650 μg of R. bovallii venom only killed one of two chickens at the 
maximum inoculated dose (14 μg/g), with death occurring around 18 h 
post-injection. Instead, a toxicovenomics analysis in R. bovallii’s 
preferred prey, lizards e.g., baby green iguana, showed that both the 
major monomeric and minor dimeric 3FTxs at doses equivalent to 
7.1–14.1 μg venom/g iguana body weight, 1 out of 3 animals was 
completely and irreversibly paralysed by 3 h post-injection and died 
overnight, <10 h later. At 450 μg/iguana (25.8–28.1 μg venom/g body 
weight) 100% (3/3) of the animals were immobilised entirely, but 
breathing, between 10 and 180 min post-injection. An identical effect 
was observed at the highest amount of venom injected (900 μg/iguana; 
49–56 μg venom/g body weight), but at this dose all (3/3) iguanas 
collapsed between 10 and 35 min after venom administration, but only 
died hours later without showing during that time any signs of recovery. 
From these data, an “LD50′′ of 315 μg/iguana was estimated, although 
this value was associated to broad 95% Confidence Intervals (CI95%, 
62–569 μg/iguana). The fact that venom produces an irreversible 
immobilisation of the prey, which will then be swallowed alive, supports 
rapid prey immobilisation as the major role for the Costa Rican false 
coral snake venom, and questions the ecological meaning of LD50 in this, 
and likely other snake venoms. Perhaps it would be appropriate to 
define the irreversible immobilising activity of a venom as “the minimal 
dose of venom that induces irreversible immobilisation of the prey". 
6.3. Toxicovenomics in preclinical research: allometric dose translation 
between model animals and human 
In preclinical research, toxicovenomics complements antivenomics 
by uncovering the identity and lethal potential of the individual venom’s 
toxins, thus informing which toxins should be primarily neutralised by 
an effective antivenom. In this sense, research on the likely toxic ac-
tivities of venom from a snake species exhibiting a generalised or spe-
cialised diet towards endothermic prey, and how it would impact 
humans will involve the use of a laboratory animal of similar physiology 
to the victim, i.e. rodents. Making sense of the outcome of animal 
research in the context of human envenoming requires allometric dose 
translation between animal and human (West and Brown, 2005; Nair 
and Jacob, 2016). Allometry is used to describe how traits covary with 
body size, such as body surface area (BSA) and mass (White and Sey-
mour, 2005). Allometric scaling is also an empirical approach where the 
exchange of drug dose is based on normalisation of dose to body surface 
area, and is used in research to predict an approximate dose on the basis 
of data existing in other species using the equation HED (human 
equivalent dose [mg/kg]) = animal dose [mg/kg] x [animal Km/human 
Km], where the correction factor (Km) is estimated by dividing the 
average body weight (kg) of the species to its body surface area (m2). For 
an average human body weight of 65 kg, and a body surface area of 1.75 
m2 (calculated using the formula human body surface area (BSA) =
[(weight [kg] x height [cm])/3600]1/2 (Mosteller, 1987; Verbraecken 
et al., 2006)), the Km factor for human is 65/1.75 = 37, whereas Km for 
a 20 g mouse is 3 (consult Table 1 in Nair and Jacob, 2016). Thus, 
allometric scaling of Egyptian cobra (Naja haje) i.p. LD50 for mice (20 g) 
of 1.8 μg/g mouse body weight translates into an LD50 for human of 
0.15 mg/kg or 9.5 mg venom/65 kg person. For an estimated yield of 
175–300 mg wet venom (52.5–100 mg dry proteins) (Branch, 1981; 
Mirtschin et al., 2006), a severe bite may deploy 6–11 median lethal 
doses into the victim. The amount of venom injected forms part of the 
“context” of a given snakebite treatment. Thus, for an antivenom dose to 
be effective in context – i.e. to possess ecological validity – it must be 
capable of neutralising at least 11 lethal doses of N. haje venom. 
The venom of the Egyptian Cobra, N. haje, comprises a minor 
α-neurotoxin (αNTxs, 7.3 kDa, 9% of the total venom proteins) and two 
major cytotoxins (CTx-1, 32% (6.7 kDa) and CTx-2, 44% (6.8 kDa) of the 
venom proteome). Toxicovenomics analysis revealed disparity in LD50s 
of 0.4, 6.6, and 6 mg/kg mouse body weight, respectively, for the αNTx 
and cytotoxins CTx-1 and CTx-2 (JJC, data not published). These data 
correspond to allometrically calculated human LD50s [mg/human of 65 
kg body weight] of 1.95 (αNTxs), 34.5 (CTx-1) and 31.5 (CTx-2). TS for 
these toxins are 45.6 (αNTxs), 2.38 (CTx-1), and 2.63 (CTx-2), clearly 
indicating that the major contributor to the venom’s lethality are the 
α-NTXs. In an average 76 mg venom snakebite, the calculated number of 
LD50s deployed into a 65 kg human victim are unevenly distributed 
between the α-NTxs (3.5 LD50s) and the cytotoxins (CTx-1, 0.69 LD50s; 
CTx-2, 1.05 LD50s), highlighting the challenge for an effective anti-
venom to neutralize all three major 3FTxs present in the venom, but 
particularly the α-NTxs. According to allometric scaling predictions, 
only a mild snakebite, consisting of less than 20 mg of injected venom, 
would deploy sublethal amounts of any toxin into a victim, and in an 
envenoming where the amount of venom injected is in the range of 
20–70 mg, only the α-NTXs would be life-threatening to the envenomed 
adult person. However, these calculations may vary if various toxins act 
synergistically. 
6.4. Allometric scaling in ecological venomics 
Continuing with the same species selected to illustrate the concept of 
allometry in preclinical venomics, in this section we highlight the rele-
vance of allometric scaling in ecology in general, and ecological ven-
omics in particular. The Egyptian cobra ranges across most of North 
Africa north of the Sahara, across the savannas of West Africa to the 
south of the Sahara, south to the Congo basin and east to Kenya and 
Tanzania. Knowledge on its dietary habits is based primarily on anec-
dotal data, suggesting they prey on a variety of small vertebrates, such as 
anurans, mammals, tortoises, birds and their eggs, lizards, fish, and 
occasionally snakes, including conspecifics (Schleich et al., 1996; Filippi 
and Petretto, 2013). Snake venom potency is generally prey-specific 
(Mebs, 2001; Healy et al., 2019). However, the potency of Egyptian 
cobra venom, and that of the vast majority of venomous snakes, has been 
studied only in the murine model, and venomics studies across its broad 
range and wide variety of habitats (steppes, dry to moist savannas, arid 
semi-desert regions with some water and vegetation) have not been 
reported. Adopting the “contextual stance” of evolution and ecology, 
this variation in diet and habitat is likely correlated with variation in 
venom composition and potency, including variations in potency to-
wards distinct prey taxa. 
Since the publication of Kleiber’s influencial monograph, a great deal 
of effort has been invested in the investigation of both basal metabolic 
rate (BMR) scaling of drug doses from experimental animals to human, 
and the adaptive significance of BMR (Kleiber, 1932). During the last 35 
years, investigation of BMR variation has gained prominence in ecology, 
and many studies have addressed the adaptive variation in BMR by 
correlating it with traits of interest (White and Seymour, 2005). 
Morphological and metabolic scaling result from adaptations evolved in 
the context of both physico-chemical and ecological constraints 
(reviewed by Glazier, 2005; but read also Magalhlaes Magalhaes Silva 
et al. (2018) regarding the interesting case of aquatic adaptations in a 
neotropical aquatic coral snake Micrurus surinamensis). Theoretical 
models of metabolic scaling have been proposed to explain interspecific 
relationships, including adaptive maximisation of foraging efficiency 
and maximisation of reproductive fitness. A ‘metabolic-level boundaries 
hypothesis’ focusing on two major constraints (surface-area limits on 
resource/waste exchange processes and mass/volume limits on power 
production), conceptually similar to the allometric dose translation be-
tween model animals and human discussed above, can explain much but 
not all the models of metabolic scaling with body mass (White et al., 
2007). 
A debate about the value of the allometric scaling exponent (b) 
relating metabolic rate (MR) to body mass (M) (MR = aMb) is still 
ongoing (Farrell-Gray and Gotelli, 2005; Glazier, 2005; White et al., 
2007). A meta-analysis of 127 interspecific allometric exponents showed 
lack of support for a single exponent model (White et al., 2007). The 
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analysis showed that the effect of size of mass on metabolic rate is 
significantly heterogeneous and that, on average, this effect is stronger 
for endotherms than for ectotherms. Significant differences between 
scaling exponents were also identified between ectotherms and endo-
therms, as well as between metabolic states (e.g., rest, field, and exer-
cise). The absence of a universal metabolic allometry represents a 
significant challenge to any model between taxa or between metabolic 
states. A complete understanding of metabolic scaling will require the 
identification of both proximate (functional) and ultimate (evolu-
tionary) causes. 
6.5. Integrating biological reality into preclinical evaluation of antivenom 
efficacy 
Preclinical studies of antivenom efficacy are typically based on 
elucidating the potency of antivenom against the potential lethal effects 
of venom in a model laboratory animal, generally mice. WHO considers 
the (murine) median effective dose (ED50) of antivenom to be a critical 
preclinical assessment bioassay that should be performed by manufac-
turers for all antivenoms, and enforced by the National Regulatory Au-
thorities (NRAs) as part of the antivenom licensing procedure (WHO, 
2017). The assay measures the dose of antivenom that prevents the 
death of 50% of test animals and may be reported in a number of ways 
(e.g.: mg venom/mL antivenom, μl antivenom/mg venom, mg ven-
om/gram antivenom, etc.) (Ainsworth et al., 2020). The relevance to 
biological reality lies only in the premise that a product that prevents 
death in an animal model might also do the same in humans, albeit 
under different dosing, physiological and pharmacokinetic conditions. 
As we have discussed some venoms do not necessarily have death as 
primary endpoint; immobilisation, pre-digestion or pain (in the case of 
predator deterrence) may be the objective. Potency has been linked to 
prey-specificity and venom yields (the mass of venom the species pro-
duces in its venom glands), parameters that are likely associated with 
spatial environment, body size, metabolism (Healy et al., 2019; De 
Roodt et al., 2016), phenotypic, geographical and sexual factors (Mirt-
schin et al., 2002). How a venom is used also influences the type and 
quantity of venom produced. By relying on neutralisation of lethality in 
isolation the true biological context of antivenom design is often 
ignored, resulting in antivenoms that are ineffective in ‘field conditions’ 
where the ability to achieve clinical ‘cure’ (the objective of treatment) is 
crucial. 
No minimum potency specifications currently exist for antivenoms 
marketed in sub-Saharan Africa (Gutiérrez et al., 2017b). Most products 
in the market have copied the specifications of FAV-Afrique and claim to 
neutralize a minimum of 200–250 murine (m) LD50 doses of each venom 
against which efficacy is claimed. The reality, however, is that neither 
yield of venom, nor mass of injected venom are equal across species. 
While 250 (m) LD50s/vial against Echis ocellatus venom from Ghana 
(LD50: 26.41 μg/19 g mouse) translates into 6602 μg venom, 250 
LD50s/vial against Naja haje venom from Ugandan specimens (LD50: 
1.90 μg/19 g mouse) is equal to 475 μg. When these figure are allo-
metrically scaled to humans (LD50 E. ocellatus Ghana: 7.35 mg/65 kg 
human; LD50 N. haje Uganda: 0.52 mg/65 kg human), and the average 
venom yields are considered (E. ocellatus: 11.2 mg; Naja haje: 314.3 mg), 
it becomes clear that while 1.7 vials could potentially neutralize 50% of 
the lethality of E. ocellatus, the number needed for N. haje could be at 
least 604 vials (JJC, unpublished). However, current antivenom in-
structions for use recommend the same (typically small) doses be 
administered regardless of the species involved (DJW, unpublished). 
Venom yields obtained during laboratory-based venom extractions are 
typically much larger than the masses of venom released by snakes 
delivering defensive bites. For example, the mass of venom injected by 
the dreaded Dendroaspis polylepis during single defensive bites was 
68.5% ± 12.5% less than the yield obtained from the same snakes during 
laboratory extractions (DJW, unpublished). Incorporating biologically 
relevant data such as mass of injected venom during defensive strikes 
and calculated human LD50 figures into the evaluation of preclinical 
antivenom efficacy could greatly improve formulation of products to 
ensure that they are likely to be effective against all of the species they 
are designed for use against. Similarly greater emphasis should be given 
to the specific activity of venom and the likely endpoints of envenoming. 
For example, antivenoms for species that are predominantly dermone-
crotic or myotoxic should be assessed for their specific ability to abro-
gate these effects (WHO, 2017; Gutiérrez et al., 2017a) since lethality is 
often rare after bites by these species. 
7. Concluding remarks and perspectives 
Snakebite envenoming is a multifactorial health crisis afflicting the 
tropical developing world (WHO, 2019), which arises as a consequence 
of ecological interactions between humans and venomous snakes. The 
complexity of snakebite envenoming emerges from the reciprocal in-
fluence of the many factors involved – an interdependence that is 
characteristic of biological phenomena at all levels of analysis. Under-
standing such complex phenomena requires a combination of descrip-
tive and explanatory knowledge. Descriptive knowledge consists of 
answers to “what?” questions – e.g., “what is there?” and “what is 
happening?“. Explanatory knowledge, on the other hand, consists of 
answers to “why?” questions – “why are things one way and not 
another?“. The achievement of explanatory understanding is contingent 
on the amassing of large quantities of descriptive knowledge – only 
when information about a large and diverse array of particulars is 
assembled can general patterns begin to be discerned. 
In the present essay, we have detailed a number of approaches to the 
acquisition of highly resolved descriptive knowledge concerning the 
composition (venomics); activity and potency (toxicovenomics); and 
neutralisation (antivenomics and neutralisation assays) of snake 
venoms. In addition, we have provided perspectives, leveraging the 
contextual stance of ecology and evolutionary biology that provide a 
pathway towards explanatory knowledge. Mitigating the burden of 
snakebite envenoming will require strategies as multifactorial as the 
problem itself, including biotechnological approaches (e.g., knowledge- 
based refurbishing current antivenoms, creating recombinant anti-
bodies, identifying small molecule inhibitors, etc. -Casewell et al., 2020) 
and health infrastructure engineering that have not been discussed in 
detail here. There is much work to be done. The specifics of venom 
variation and its impact in the clinical management of snakebite enve-
nomings remain completely unknown, and thus our knowledge of the 
ecological validity of antivenoms against the venom of geographic 
variants of conspecific populations is extremely limited. Through the 
treatment of snakebite envenoming as the biological phenomenon that it 
is, by bringing to bear the resources of contemporary biological science 
in concert with those of biomedical science, we believe a pathway to 
deeper understanding is being forged. Understanding the problem will 
help us to solve it. 
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Göçmen, B., Heiss, P., Petras, D., Nalbantsoy, A., Süssmuth, R.D., 2015. Mass 
spectrometry guided venom profiling and bioactivity screening of the Anatolian 
Meadow Viper, Vipera anatolica. Toxicon 107, 163–174. 
Gutiérrez, J.M., 2020. Snakebite envenoming from an Ecohealth perspective. Toxicon:X 
7, 100043. 
Gutiérrez, J.M., Calvete, J.J., Habib, A.G., Harrison, R.A., Williams, D.J., Warrell, D.A., 
2017a. Snakebite envenoming. Nature Rev. Dis. Primers 3, 17063. 
Gutiérrez, J.M., Solano, G., Pla, D., Herrera, M., Segura, Á., Vargas, M., Villalta, M., 
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Petras, D., Hempel, B.F., Göçmen, B., Karis, M., Whiteley, G., Wagstaff, S.C., Heiss, P., 
Casewell, N.R., Nalbantsoy, A., Süssmuth, R.D., 2019. Intact protein mass 
spectrometry reveals intraspecies variations in venom composition of a local 
population of Vipera kaznakovi in Northeastern Turkey. J. Proteomics 199, 31–50. 
Pla, D., Gutiérrez, J.M., Calvete, J.J., 2012. Second generation snake antivenomics: 
comparing immunoaffinity and immunodepletion protocols. Toxicon 60, 688–699. 
Pla, D., Sanz, L., Molina-Sánchez, P., Zorita, V., Madrigal, M., Flores-Díaz, M., Alape- 
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